We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

103 hedge funds and large institutions have $456M invested in Foundation Medicine, Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more call options, than puts

Call options by funds: $40.2M | Put options by funds: $15.5M

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

26% more capital invested

Capital invested by funds: $362M → $456M (+$94.2M)

11% more funds holding

Funds holding: 93103 (+10)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
103
Holders Change
+10
Holders Change %
+10.75%
% of All Funds
2.56%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
19
Increased
37
Reduced
24
Closed
9
Calls
$40.2M
Puts
$15.5M
Net Calls
+$24.8M
Net Calls Change
+$23M

FMI Hedge Fund Activity: Q2 2017 in Review

103 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2017, worth a combined $456M — up 26% from $362M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FMI positions and 9 closed out — a net gain of 10 holders — while 37 added to existing stakes and 24 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $12.6M. The largest seller was Discovery Group I, cutting an estimated $17.4M.

  • 103 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2017, up from 93 in Q1 2017.
  • Funds reported $456M of Foundation Medicine, Inc. stock for Q2 2017, up 26% quarter-over-quarter.
  • 19 funds opened new Foundation Medicine, Inc. positions in Q2 2017 and 9 closed out, a net change of +10 holders.
  • The largest Foundation Medicine, Inc. buyer in Q2 2017 was Lord, Abbett & Co, an estimated $12.6M added.
  • The largest Foundation Medicine, Inc. seller in Q2 2017 was Discovery Group I, an estimated $17.4M sold.

Based on aggregated 13F filings for Q2 2017.